Federal Government says States that have not met the criteria for vaccine safety will not get doses

Executive Director, National Primary Health Care Development Agency, Dr Faisal Shuaib said that states have not met the criteria for vaccine safety will not get doses of AstraZeneca/Oxford COVID-19 vaccines in the country.

Dr Shuaib, disclosed this at the State House in Abuja on Thursday.

Shuaib, who had earlier allayed the fears of Nigerians about being vaccinated, asked those who want to be vaccinated to apply online

Shuaib said, “After we are able to get our strategic leaders to publicly demonstrate that these vaccines are safe, the plan is to now go to the state level to start the launch at the treatment centres of the states and also get strategic leaders such as governors to publicly take the vaccines.

“By the time all of these happen, we will have finished all of the necessary preparations, we will have created a dashboard that will track very carefully the status of the preparedness of the states.

“We will not be sending vaccines to the states that have not fulfilled all of the criteria that will ensure that if the vaccines get to the states, they are going to be safe.

“For example, we have communicated to the states that they have to wrap up their security around their cold stores because these are very valuable vaccines and we do not want a situation where vaccines are taken to the states and criminal elements take advantage to vandalise these cold stores.

“We are also aware that during the #EndSARS vandalisation, there were some cold stores that actually suffered. I know that the state governors are trying to fix those but we have to verify that those are ready to receive our vaccines.

“We are working with the sub-national level; we are in conversation with the Nigerian Governors’ Forum to see how Nigerians can rapidly get their vaccines. It is very critical that we roll out rapidly so that we can cut into any kind of mutation that can lead to the development of resistance against our vaccines.”

Leave a Comment

Your email address will not be published. Required fields are marked *